Cormedix's market cap is currently ―. The company's EPS TTM is $-0.917; its P/E ratio is -5.85; Cormedix is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	$ 29.70K
Gross Profit	-	-	-	-	$ 29.30K
EBIT	$ -14.75M	$ -9.73M	$ -11.27M	$ -10.56M	$ -8.38M
EBITDA	$ -14.69M	$ -9.68M	$ -11.22M	$ -10.51M	$ -8.33M
Net Income Common Stockholders	$ -14.75M	$ -9.74M	$ -11.27M	$ -10.57M	$ -8.21M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 76.03M	$ 86.59M	$ 52.49M	$ 55.73M	$ 58.92M
Total Assets	$ 82.06M	$ 91.43M	$ 57.03M	$ 59.23M	$ 62.04M
Total Debt	$ 668.00K	$ 702.95K	$ 736.86K	$ 770.01K	$ 802.43K
Net Debt	$ -75.36M	$ -85.88M	$ -51.75M	$ -54.96M	$ -58.11M
Total Liabilities	$ 11.92M	$ 8.23M	$ 7.98M	$ 5.31M	$ 6.98M
Stockholders Equity	$ 70.14M	$ 83.20M	$ 49.05M	$ 53.93M	$ 55.06M
Cash Flow	-
Free Cash Flow	$ -11.04M	$ -8.71M	$ -8.58M	$ -10.41M	$ -6.28M
Operating Cash Flow	$ -10.75M	$ -8.70M	$ -8.57M	$ -10.39M	$ -6.15M
Investing Cash Flow	$ 597.79K	$ -586.87K	$ -2.39M	$ -14.69M	$ -1.86K
Financing Cash Flow	$ 467.65K	$ 42.90M	$ 5.35M	$ 7.20M	$ 6.05M

Currency in USD

Cormedix Earnings and Revenue History

Income Statement >

Cormedix Debt to Assets

Balance Sheet >

Cormedix Cash Flow

Cash Flow >

Cormedix Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing